When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries

PLoS Neglected Tropical Diseases

Volumn 3, Issue 6, 2009, Pages

  Ray, Kathryn J ^a   Lietman, Thomas M ^a,b   Porco, Travis C ^a,b   Keenan, Jeremy D ^a,b   Bailey, Robin L ^c   Solomon, Anthony W ^c   Burton, Matthew J ^c   Harding Esch, Emma ^c   Holland, Martin J ^c   Mabey, David ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COMPUTER SIMULATION; COST CONTROL; ETHIOPIA; GAMBIA; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; STOCHASTIC MODEL; TANZANIA; TRACHOMA; CHLAMYDIA TRACHOMATIS; DRUG EFFECT; DRUG UTILIZATION; FEMALE; INFANT; MALE; PRESCHOOL CHILD; STANDARD; THEORETICAL MODEL;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; DRUG UTILIZATION; ETHIOPIA; FEMALE; GAMBIA; HUMANS; INFANT; MALE; MODELS, THEORETICAL; PREVALENCE; TANZANIA; TRACHOMA;

EID: 68349105113     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000458     Document Type: Article

References (28)

1. Shapiro B, Dickersin K, Lietman T (2006) Trachoma, antibiotics and randomised controlled trials. Br J Ophthalmol 90: 1443-1444.
2. Bailey RL, Arullendran P, Whittle HC, Mabey DC (1993) Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 342: 453-456.
3. Dawson CR, Schachter J, Sallam S, Sheta A, Rubinstein RA, et al. (1997) A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 24: 363-368.
4. Schachter J, West SK, Mabey D, Dawson CR, Bobo L, et al. (1999) Azithromycin in control of trachoma. Lancet 354: 630-635.
5. Gaynor BD, Miao Y, Cevallos V, Jha H, Chaudary JS, et al. (2003) Eliminating trachoma in areas with limited disease. Emerg Infect Dis 9: 596-598.
6. Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, et al. (2004) Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 292: 721-725.
7. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, et al. (2004) Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 351: 1962-1971.
8. Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, et al. (2005) Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365: 1321-1328.
9. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, et al. (2005) Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366: 1296-1300.
10. Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, et al. (2006) Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 295: 1142-1146.
11. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D (2006) Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. JAMA 296: 1488-1497.
12. Gill DA, Lakew T, Alemayehu W, Melese M, Zhou Z, et al. (2008) Complete elimination is a difficult goal for trachoma programs in severely affected communities. Clin Infect Dis 46: 564-566.
13. Solomon AW, Harding-Esch E, Alexander ND, Aguirre A, Holland MJ, et al. (2008) Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Engl J Med 358: 1870-1871.
14. Melese M, Alemayehu W, Lakew T, Yi E, House J, et al. (2008) Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA 299: 778-784.
15. Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, et al. (2002) Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 35: 395-402.
16. Peeling RW, Toye B, Jessamine P, Gemmill I (1998) Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect 74: 66-70.
17. Diamant J, Benis R, Schachter J, Moncada J, Pang F, et al. (2001) Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol 8: 109-117.
18. Michel CE, Solomon AW, Magbanua JP, Massae PA, Huang L, et al. (2006) Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study. Lancet 367: 1585-1590.
19. Solomon AW, Foster A, Mabey DCW (2005) Single dose azithromycin for trachoma: author reply. N Engl J Med 352: 414-415.
20. Lee DC, Chidambaram JD, Porco TC, Lietman TM (2005) Seasonal effects in the elimination of trachoma. Am J Trop Med Hyg 72: 468-470.
21. Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, et al. (2007) A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis 7: 91.
22. Anderson R, May R (1991) Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press.
23. Lakew T, House J, Hong KC, Yi E, Alemayehu W, et al. (2009) Reduction and return of infectious trachoma from a severely affected region of Ethiopia. PLoS Negl Trop Dis 3: e376. doi:10.1371/journal.pntd.0000376.
24. Mecaskey JW, Knirsch CA, Kumaresan JA, Cook JA (2003) The possibility of eliminating blinding trachoma. Lancet Infect Dis 3: 728-734.
25. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477-483.
26. Bird M, Dawson CR, Schachter JS, Miao Y, Shama A, et al. (2003) Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas? J Infect Dis 187: 1669-1673.
27. Yang JL, Lietman TM (2007) The return of trachoma in partially treated communities. Arch Ophthalmol 125: 989-991.
28. Solomon AW, Mohammed Z, Massae PA, Shao JF, Foster A, et al. (2005) Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. Antimicrob Agents Chemother 49: 4804-4806.